SEC Form 4 · accession 0001225208-16-036911
BOSTON SCIENTIFIC CORP · BSX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael P. Phalen
Officer — EVP & President, MedSurg
Period of report
Jul 20, 2016
Accepted (ET)
Jul 20, 2016 · 4:29 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000885725
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Jul 20, 2016 | M | 35,000 | $12.52 | A | 124,309 | D | |
| Common StockF2 | Jul 20, 2016 | S | 35,000 | $24.03 | D | 89,309 | D | |
| Common StockF3 | holding | — | — | — | 2,424 | I | By 401(k) |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F4 | $12.52 | Jul 20, 2016 | M | 35,000 | D | — | Feb 12, 2018 | Common Stock | 35,000 | 34,773 | D |
Explanation of responses
- F1This transaction was effected pursuant to a pre-established Rule 10b5-1 trading plan.
- F2Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available.
- F3Balance reflects the most current data available with regard to share holdings in the Company's 401(k) Retirement Savings Plan.
- F4Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual increments beginning on February 12, 2009, the first anniversary of the grant.